TED376656-2025

Joint Nordic Procurement of Pharmaceuticals - 2025 - NF2.1301.a

Ordregiver: Amgros I/S
Oplyst værdi / estimat: 13.922.377 EUR
Frist: —
Publiceret: 11.6.2025
CPV: 33600000
Leveringssted (NUTS): DK011, DNK

Dataposten opdateret 6. sep. 2026, 10.33. Datakilder, dækning og beregningsmetode.

Tildeling

Vinderlisten dækker bekendtgørelsen. Denne visning har ikke en sikker kobling mellem hver vinder, delkontrakt, værdi og udløbsdato. Se originalen for fordelingen.

Bekendtgørelsens samlede værdi: 227.000.000 EURKontrakt indgået: 30.9.2024

FrostPharma AB, STADA Nordic ApS, EQL Pharma AB, Fresenius Kabi, Navamedic AB, B. Braun Medical AS, B. Braun Medical A/S, Hameln Pharma ApS, Orion Pharma A/S

Registreringsnr. 556814-1708CVR 13902992Registreringsnr. 556713-3425CVR 21347809Registreringsnr. 556564-9661Registreringsnr. 914 113 172CVR 20343249CVR 39720213CVR 20601116Oplyst værdi: 227.000.000 EUR

Beløb er offentliggjorte værdier i bekendtgørelser og kan omfatte flere delkontrakter, rammeaftalelofter og estimater. De viser ikke faktisk omsætning eller forbrug. Valutaer summeres hver for sig uden omregning. Manglende beløb er ikke nul. Se datagrundlag og metode.

Beskrivelse

Denmark, Norway and Iceland have entered into cooperation regarding the procurement of pharmaceuticals. The countries will jointly procure and award framework agreements in order to ensure the supply of pharmaceuticals in the countries. In Denmark certain pharmaceuticals are resold to the Faroe Island and Greenland. Under this tender group, the pharmaceuticals are tendered under each lot no. for the purpose of supplying the Contracting Authorities as 2 markets (Norway as 1 market and Denmark and Iceland as 1 market) see the tender specification. The obligation to deliver the pharmaceuticals in Iceland is subject to the precondition that the supplier obtains an exemption regarding printed labels and leaflets. If the supplier does not obtain such exemption the agreement will only apply to Denmark and Norway, see the Framework agreement section 2.2.1 and Appendix 6.

Procedure og udbudsmateriale

Oplysninger fra bekendtgørelsen kan dække flere delkontrakter. Listerne nedenfor er separate uddrag; rækkefølgen kobler ikke et kriterium til en beskrivelse eller delkontrakt. Kontrollér krav, vægtning, frister, optioner og eventuelle rettelser i originalmaterialet.

Proceduretype (kildens kode)

open

Beskrivelser af tildelingskriterier

Price is not the only award criterion and all criteria are stated only in the procurement documents.

Oplyste optioner

Clause 8.2 of the framework agreement provides for an option for delivery in a pre-agreement period (i.e. before the purchase period begins) and an option for delivery in a post-agreement period (i.e. after the purchase period). The two options may be exercised on the terms and conditions stipulated in the framework agreement. The estimated duration in section 5.1.3 is including the options for renewals. The framework agreements ordinary duration is from 1.4.2025 to 31.3.2027.

Åbn originaludbud

Andre bekendtgørelser i samme CPV-kategori

Nyeste bekendtgørelser med samme firecifrede CPV-kategori. Listen kan omfatte både åbne udbud og historik.